Form D · Pharmaceuticals
Duo Oncology Inc.
Pittsburgh, PA · CIK 0001843372
Offering snapshot reported Aug 7, 2026 · SEC filing
- Reported sold
- $1.63M Offering amount: $3.5M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Jun 2, 2025 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$1,425,000 → $1,625,000
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 7, 2026 | Amendment | $1,625,000 | $200,000vs Jun 9, 2026 | 13 | SEC filing |
| Jun 9, 2026 | Amendment | $1,425,000 | $1,025,000vs Jun 10, 2025 | 13 | SEC filing |
| Jun 10, 2025 | Initial | $400,000 | No comparison | 8 | SEC filing |
| Aug 11, 2023 | Amendment | $4,250,005 | $1,550,005vs Feb 8, 2023 | 14 | SEC filing |
| Feb 8, 2023 | Initial | $2,700,000 | No comparison | 9 | SEC filing |
| Feb 8, 2021 | Initial | $1,125,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-548506
Source: Form D, filed Aug 7, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Ashley | Director |
| Katherine Eichinger | Executive |
| Joe Gatto | Director |
| Jing Zhou Hou | Director, Executive, Promoter |
| Song Li | Director, Promoter |
| Lusong Luo | Director |
| Victoria Manax | Director |
| Stanley Marks | Director |
| Sam Rothstein | Director, Executive, Promoter |
| Jingjing Sun | Promoter |
| Stephen Thorne | Executive, Promoter |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:Pittsburgh, PA, 15213
Phone: 412-709-1659